Motrin IB is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Johnson & Johnson Consumer Inc., Mcneil Consumer Healthcare Division. The primary component is Ibuprofen.
| Product ID | 50580-110_4e10c377-3895-4550-b6a4-9cb03805dcb2 |
| NDC | 50580-110 |
| Product Type | Human Otc Drug |
| Proprietary Name | Motrin IB |
| Generic Name | Ibuprofen |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2000-08-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019012 |
| Labeler Name | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division |
| Substance Name | IBUPROFEN |
| Active Ingredient Strength | 200 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2000-08-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2013-10-25 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2017-06-23 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2019-01-01 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2013-10-25 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2017-06-23 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2015-09-08 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2017-06-23 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2015-09-08 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2013-10-25 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2015-04-05 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2013-04-30 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2019-11-30 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2017-06-23 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2015-09-08 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-16 |
| Marketing End Date | 2017-06-23 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2018-12-31 |
| Marketing Category | NDA |
| Application Number | NDA019012 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-08-01 |
| Marketing End Date | 2019-11-30 |
| Ingredient | Strength |
|---|---|
| IBUPROFEN | 200 mg/1 |
| SPL SET ID: | 5bca517f-94a5-428c-b716-80c6b0b86980 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |